Clinical Trials Logo

Clinical Trial Summary

This is a prospective cohort study to examine the disease burden of multiple system atrophy and the impact of multidisciplinary care on quality of life and caregiver burden. Data will be collected through valid rating scales completed by patients and caregivers at home or in the MSA clinic.


Clinical Trial Description

Study Procedures: Participants and caregivers will attend a multidisciplinary MSA clinic one day every four months. In addition to the standard of care, they will be asked to complete both online and paper questionnaires, including the following: - UMSARS (Unified MSA Rating Scale) - MSA QOL - CES-D - OHQ - Compass-31 - BIC - UPDRS - SARA - MDS Scale - CGI - MoCA Participants will be part of the study as long as they are a patient of the MSA clinic, and will be contacted for follow-up information up to five years. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03811808
Study type Observational
Source University of Texas Southwestern Medical Center
Contact Amy Conger
Phone 214-648-0214
Email Amy.Conger@UTSouthwestern.edu
Status Recruiting
Phase
Start date March 2016
Completion date March 2028

See also
  Status Clinical Trial Phase
Recruiting NCT05923866 - A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy Phase 2
Recruiting NCT02778607 - PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
Completed NCT01485549 - Oligomeric Alpha-synuclein in Multiple System Atrophy
Completed NCT02796209 - Norepinephrine Transporter Blockade, Autonomic Failure Phase 2
Completed NCT04193527 - A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients Phase 3
Completed NCT01888185 - Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
No longer available NCT05086094 - Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)